Socioeconomic gradient in use of statins among Danish patients: population‐based cross‐sectional study
- 13 September 2005
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (5) , 534-542
- https://doi.org/10.1111/j.1365-2125.2005.02494.x
Abstract
Socioeconomic inequalities in statin use are a public health concern but they may also confound observational studies of statins' effectiveness. We conducted a population-based cross-sectional study in Denmark to examine the association between socioeconomic status (SES) and statin use. We obtained data on socioeconomic status of all persons in North Jutland County, Denmark, between 1995 and 1999 from the Prevention Registry at Statistics Denmark. Data on filled statin prescriptions were identified through the County Prescription Database. We compared the 1-year prevalence proportions of statin use for different socioeconomic groups, adjusted for age and urbanization. Separate analyses were done for patients with a history of cardiovascular disease as recorded in the County Hospital Discharge Registry. Among men with cardiovascular disease, statin use in 1995 was higher in those with the highest socioeconomic status (adjusted relative prevalence proportion (RPP) among top managers 1.86, 95% CI: 1.17-2.96), and lower among retired men (RPP (95% CI) 0.63 [0.43-0.93] in old-age pensioners, and 0.66 [0.45-0.98] in the early retired), when compared with basic-level workers. The socioeconomic differences in statin use among men decreased in magnitude over time but remained throughout the study period. We found no clear social gradient in statin use among women. Even in a health care system that claims to ensure a high degree of equity in medical care, we found clear indications of a socioeconomic gradient in statin use among men in the years after the launching of these drugs.Keywords
This publication has 39 references indexed in Scilit:
- Statin use after acute myocardial infarction: a nationwide study in DenmarkBritish Journal of Clinical Pharmacology, 2005
- Evidence for inequalities in the management of coronary heart disease in ScotlandHeart, 2005
- Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in EnglandJournal of Epidemiology and Community Health, 2004
- Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?Heart, 2003
- The Pleiotropic Effects of HMG-CoA Reductase InhibitorsDrugs, 2003
- Statins as novel immunomodulators: From cell to potential clinical benefitThrombosis and Haemostasis, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?Heart, 2002
- Use of lipid‐lowering drugs during 1991–98 in Northern Jutland, DenmarkBritish Journal of Clinical Pharmacology, 2001
- Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register StudyJournal of Epidemiology and Community Health, 2001